Cargando…
Association between dexmedetomidine use for the treatment of alcohol withdrawal syndrome and intensive care unit length of stay
PURPOSE: Alcohol withdrawal syndrome (AWS) is commonly treated in medical ICUs and typically requires high resource utilization. Dexmedetomidine for AWS has not been extensively investigated, and guidelines regarding its use are lacking. We evaluated the association between dexmedetomidine use in AW...
Autores principales: | Yavarovich, Ekaterina R., Bintvihok, Maythawee, McCarty, Justin C., Breeze, Janis L., LaCamera, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6829916/ https://www.ncbi.nlm.nih.gov/pubmed/31700642 http://dx.doi.org/10.1186/s40560-019-0405-1 |
Ejemplares similares
-
Addition of dexmedetomidine to benzodiazepines for patients with alcohol withdrawal syndrome in the intensive care unit: a randomized controlled study
por: Bielka, Kateryna, et al.
Publicado: (2015) -
Dexmedetomidine as adjunct treatment for severe alcohol withdrawal in the ICU
por: Rayner, Samuel G, et al.
Publicado: (2012) -
Dexmedetomidine as an anesthetic adjunct is associated with reduced complications and cardiac intensive care unit length of stay after heart valve surgery
por: Fan, Zhi-Wei, et al.
Publicado: (2023) -
Impact of Delayed Admission to the Intensive Care Unit from the Emergency Department upon Sepsis Outcomes and Sepsis Protocol Compliance
por: Agustin, Michael, et al.
Publicado: (2017) -
Length of stay in pediatric intensive care unit: prediction model
por: Brandi, Simone, et al.
Publicado: (2020)